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1. Overview 
India has engaged on a national level effort to increase the country’s capacity to innovate 
in biotechnology.  They have marked biotechnology as a national priority for sectoral 
development. At the policy level there is a national development strategy to develop biotechnology. 
They also developed a dedicated organization to serve as an innovation ecosystem enabler- the 
Biotechnology Industry Research Association Council (Department of Biotechnology, 2019). 
In 2012, India developed the Biotechnology Industry Research Association Council - a 
special purpose organization aimed at bridging a gap in the biotechnology innovation 
ecosystem. This was the first of its kind in the country developed to promote and mentor 
innovation research for affordable product development.  The organization was created by the GOI 
to promote research industry academia partnerships in response to an existing gap in the 
innovation system where there was a need for connecting research to commercial product 
development (BIRAC, 2019). 
Support by the Indian government for innovation in biotechnology is largely focused on 
start-ups and entrepreneurs to promote the translation of research ideas to commercial 
products.  Several targeted initiatives are created to promote entrepreneurship in biotechnology. 
National investment schemes and venture capital provide necessary financing and opportunities 
to support collaboration across public sector researchers and 1st generation entrepreneurs. Early 
start ups and SMEs are encouraged to innovate and develop products in key social sectors to 
address national needs (Nogrady, 2018).   
Support for innovation in biotechnology is occurring through technology transfer through 
strategic alliances with other countries focused on innovation as well. There is increasing 
evidence that these collaborations are no longer concentrated between developed countries and 
developing countries as there is an increase in partnerships taking place between developing 
countries (Konde, 2009). 
This rapid literature review has found that evidence on India’s experience and achievements in 
biotechnology is largely generated by government reports and state agency websites. A review of 
academic studies, government publications and Government of Indian websites, as well as reports 
issued by different development agencies was conducted to gather evidence on achievements in 
the Indian experience of innovation in biotechnology. Much of the evidence gathered is based on 
Government of India reports. 
The report particularly focuses on the evidence from India’s innovation experience on the health, 
agriculture, clean energy and waste to value sectors.  The literature on these sectors mainly 
focuses on what has been achieved with sector specific evidence on how innovation was 
supported in specific programmes and projects. Some of the key examples gathered address 
varying levels of innovation development. These include national level sectoral strategies, policy 
development, incubation, international collaborations and support for commercialization of ideas. 
Examples include: 
 The Access to Clean Energy Programme jointly implemented by the government and the 
UNDP piloted community level vericompost biodigesters in Karnataka provides a case of 
both clean energy access and waste to value. The programme aimed to provide access to 
clean energy in rural areas while enabling households to earn income by making saleable 
fertilizer from biogas (UNDP, 2010). 
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 The Village Energy Security Programme (VESP) in 2005 - a large country wide pilot 
programme in biomass was executed to test models for supplying biomass power 
generation in rural areas. However, was stopped because it was unsuccessful due to 
operational issues and lack of coordination among stakeholders (Palit et. al 2013). 
 India has emerged as one of the leading countries in the world in promoting local R&D in 
agricultural biotechnology in general and genetically modified GM-crops in particular.  
However, policies especially between central and state level, to tackle the many complex 
problems that face product development, testing and commercialisation of transgenic 
crops in India are in need of improvement to facilitate further development (Ananth, 2015) 
 The National Biopharma Mission is a national level sectoral strategy that supports 
innovation through an industry- academia collaborative mission of Department of 
Biotechnology in collaboration with the World Bank for accelerating discovery research to 
early development of Biopharmaceuticals and to be implemented by Biotechnology 
Industry Research Assistance Council (BIRAC). Innovation support includes: product 
development that aims to meet public health needs; infrastructure development and 
incubation of new ideas; accelerating research; developing human capital and technology 
transfer (National Biopharma Mission, 2019) 
 The UK Research and Innovation (UKRI) consortium, and the Department for 
Biotechnology (DBT) India, supports innovation through multidisciplinary research 
collaborations between the academic and industrial communities based in the UK and 
India. Support for innovation focuses on multidisciplinary research collaborations between 
the academic and industrial communities based in the UK and India (UK Research and 
Innovation, 2018). 
The report is structured as follows. Section 2 briefly discusses the Indian approach to 
innovation specifically on its efforts to enable the innovation ecosystem through the BIRAC. 
Section 3 provides evidence on India’s innovation experience with biotechnology with a 
sectoral focus on health, agriculture, waste to value and clean energy; and section 4 provides 
examples of biotechnology innovation programmes and highlights findings on how innovation 
was supported in these.  
 
2. Indian Approach to Innovation in Biotechnology 
India’s biotechnology development strategy aims to establish the country as a world-class 
bio-manufacturing hub. The development process of biotechnology is currently guided by its 
national policy titled, “National Biotechnology Development Strategy 2015-2020”. It intends to 
launch a major mission, backed with significant investments, for the creation of new biotech 
products, create a strong infrastructure for R&D and commercialization, and empower India’s 
human resources scientifically and technologically (Department of Biotechnology, 2019). Key 
priorities include: 
 Making India ready to meet the challenge of achieving a US$100bn bioeconomy by 2025 
(India BioEconomy Report, 2019 p.7) 
 Creating a Technology Development and Translation Network across the country with 
global partnerships 5 new clusters, 40 Biotech incubators and 20 Bio-connect centres 
 Launch four major missions in healthcare, food and nutrition, clean energy and education 
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India developed a special purpose organization in 2012 (i.e. Biotechnology Industry 
Research Assistance Council (BIRAC)), which is aimed at bridging a gap in the 
biotechnology innovation ecosystem. The organization was the first of its kind in the country 
and was developed to promote and mentor innovation research for affordable product 
development. BIRAC was created by the Government of India (GOI) in response to an existing 
gap in the innovation system in India where there was a need for promoting partnerships between 
industry and academia – so that research could be taken through the translational phase to product 
development. To translate scientific research into commercially viable products, BIRAC provides 
funding, mentoring, capacity building, and infrastructure in their programming. It acts as an enabler 
of the Indian biotechnology innovation ecosystem (BIRAC, 2019). 
BIRAC identifies gaps and challenges facing biotechnology entrepreneurs and responds 
by creating targeted programming to address the needs of these start-ups/entrepreneurs. 
It supports projects at each stage of the ‘innovation cycle’ – starting from ideation, to testing for 
proof of concept (POC), to late stage product development, and finally its commercialisation in the 
marketplace (BIRAC,2019).  
 
2.1 The BIRAC model  
BIRAC’s support to the development of Indian bioeconomy focuses on biotech start-ups 
and small and medium-sized enterprises (SMEs) as well as on raising their capabilities.  
BIRAC notes that a current issue in the Indian biotechnology industry is the lack of mentorship of 
biotechnology entrepreneurs on how to take ideas to proof of concept. As a result, targeted 
programs were created to allow for handholding, financing and mentorship to bridge the gap from 
ideation to proof of concept (BIRAC, 2019). This literature review has noted that there is an 
absence of independent assessments on the results produced by BIRAC. However, achievements 
documented to date by BIRAC included (BIRAC, 2019): 
 Generating 180 Intellectual Property Rights (IPs); 
 Supporting 45 bio-incubators across India – that have developed 133 products and 
technologies to the market; 
 Supporting 682 start-ups, which have generated 125 million USD;  
 Creating 767 jobs through incubators; and 
 Supporting 973 beneficiaries through funding, mentorship, capacity building. 
 
BIRAC has been a pioneer in funding and nurturing innovative ideas through its Biotech 
Ignition Grant Programme (BIG). The grant was launched in 2012 and was aimed at creating 
and seeding viable biotech start-ups.  The programme has been instrumental in encouraging 
innovation among young entrepreneurs to test their ideas and bring them to the Proof of Concept 
stage.  The program offered (BIRAC, 2019): 
 18-month business incubation with seed funding of approximately 70,000 USD1; 
                                                   
1 BIRAC (2019) Biotech Ignition Grant Programme: https://birac.nic.in/big.php  
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 Collaboration with international research institutions, such as the Judge Business School 
– University of Cambridge for knowledge and learning;  
 Creation of 25 biotechnology incubator hubs across the country that will focus on medical 
devices, bio-pharma, vaccines & diagnostics and Industrial biotechnology. The bio-
incubators provide the incubation space and other required services for entrepreneurs and 
start-up companies for their initial growth; 
 Handholding support to start-ups to: foster generation of ideas with commercialization 
potential, upscale and validate proof of concept, encourage researchers to take technology 
closer to market through a start-up and stimulate enterprise formation. 
 
3. General Evidence on India’s Innovation Experience with 
Biotechnology 
Rose (2004) noted that most studies on biotechnology are descriptive (i.e. primarily 
qualitative in nature) and, therefore, fail to provide firm specific data and analysis. Further, 
while these studies depict biotechnology as an enabling factor, they do not give a full picture of its 
dynamics. Also, in the case of India, clear indicators that can capture the nature and complexity of 
innovation being imbibed by biotechnology firms are unavailable (Chaturvedi, 2005). 
The following sections synthesizes information on the Indian experience of biotechnology in 
biomass energy (clean energy), agricultural biotechnology, health technology and waste-to-value. 
3.1 Clean Energy 
India is committed to enhancing innovation toward a clean energy transition. The country 
has signed a Memorandum of Understanding (MoU) with the International Energy Agency (IEA) 
on ‘Enhancing Innovation for the Clean Energy Transition’ on August 30, 2018.  This MOU is a 
joint program under ‘Mission Innovation’ which is a global initiative of 24 countries and the 
European Commission (on behalf of the European Union).These 25 members have committed to 
seek to double public investment in clean energy R&D and are engaging with the private 
sector, fostering international collaboration and celebrating innovators (Mission Innovation, 2019 
a).   
As part of Mission Innovation, India was able to advance research on indigenous 
technology to convert biomass to ethanol along with speed and efficiency by converting 
agricultural waste into ethyl alcohol or bio-ethanol. Its first Second-Generation (2G) Ethanol plant 
to build commercial scale biomass ethanol plants based on the home-grown technology and was 
developed under a project of the Ministry of Science and Technology.  To do this, the government 
supported and incentivised research into technologies, resource assessment and system 
modelling of the biomass energy sector (Department of Biotechnology, 2019). 
Additionally, a large country wide pilot programme in biomass was executed to test models 
for supplying biomass power generation in rural areas. The Village Energy Security 
Programme (VESP) in 2005 was rolled out to go beyond electrification alone, and address the total 
energy needs (i.e. cooking, lighting, and productive use) of remote villages by using local biomass 
resources.  At the end of the project, about 700 kW of electricity generation equipment was installed 
of which nearly 90% was biomass-based gasifier technology (World Bank, 2011).   
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India’s experience in renewable energy ranges in technologies and devices, such as 
improved cook stoves, biogas plants for various applications, biomass gasifiers using 
different feedstock's, solar photovoltaic lighting, solar thermal water heating systems and 
water mill from different parts of the country, appropriate to rural areas and capable of 
providing access to clean energy in rural areas. According to a UNDP report on access to 
energy in India, the innovativeness is not only in the technology application for various end uses 
but also in developing and implementing a sustainable delivery and revenue model. An example 
is SKG Sangha (SKGS) – a non-profit organization based in Kolar district of Karnataka. The 
organisation is setting up hybrid vermicompost biodigesters in rural Karnataka and in other states 
of India. This has the twin objectives of i) providing clean cooking gas generated through biogas 
to these rural areas and ii) to enable the rural households to earn additional income by making 
saleable fertilizer from biogas residue and other unmanaged agricultural and domestic organic 
wastes (UNDP, 2010). 
Biomass is a good example of Indian advancement in industrial biotechnology and it has 
been prioritized for sectoral support from the government – both at the national and state 
level. As per the Ministry of New and Renewable Energy (MNRE) of GOI, a total of 288 biomass 
power and cogeneration projects aggregating to 2665 MW capacity have been installed in the 
country for feeding power to the grid (UNDP, 2010) 
Balachandra (2011) has listed several points in favour of adopting modern biomass energy, 
especially for rural India.  The author noted that: (i) biomass resources potential in India is high 
to produce adequate amount of modern energy, (ii) advanced biomass energy technologies for 
decentralized utilization in rural areas have reached near commercialization, (iii) India has local 
expertise in developing and deploying biomass gasifier technologies for power generation and bio-
methanation technologies for biogas production, (iv) scopes for medium, small and micro scale 
rural enterprises are large – which would help to promote rural income generation and 
employment. 
However, even with decades of experience in managing biomass power in India, gaps still 
exist in the supply chain. The main scope for interventions conducted in India are in collection 
and mobilization of the raw material to the plant, technical upliftment of the processing units 
(including both bio as well as thermo plants), improving design and engineering aspects, promoting 
performance monitoring and management systems, conducting feasibility studies and carrying out 
focused research and development (Denmark in India, 2019). 
Central to the development of the sector is the Biotechnology Industry Research 
Association Council, where businesses are supported from research and testing of ideas 
to commercial products. An example of a recent achievement in the commercialization of 
biomass has been India’s 1st Second-Generation (2G) Ethanol plant which was inaugurated in 
2018 (Make in India, 2019). 
Biomass has now become an important energy source for the country. Currently, about 32% 
of total primary energy used in India is derived from Biomass. More than 70% of the country’s 
population depends upon biomass for its energy needs (Denmark in India, 2019). Biomass projects 
throughout India address issues of lack of access to conventional electricity in rural areas, 
affordability, dependence on diesel fuel, and generation of employment.  Government policy 
incentives along with R&D support are central to the development of the sector although there 
have been several pilot projects for testing biomass and other rural renewable energy projects led 
by NGO’s and international development programs (UNDP, 2010). 
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3.2 Agriculture Biotechnology 
India has emerged as one of the leading countries in the world in promoting local R&D in 
agricultural biotechnology in general and GM-crops in particular. Further, it has experience 
in the functioning of comprehensive biotechnology and biosafety regimes that regulate the 
introduction and commercialisation of GM-crops and GM-products (Ananth, 2015). this is important 
since India is an agriculture-based country, where more than 50% of population is dependent on 
agriculture (Madhusudan, 2015).   
The country’s agricultural biotechnology sector made strides in the 1990s in Ribosomal 
DNA, transgenics and molecular marker assisted plant breeding processes. The 
Government of India responded with a matching policy support and regulatory framework 
that was designed to render the path of progress in R&D to be sustainable and bio-safe. To 
a large extent, developments in the policy front have been induced by a vibrant non-governmental 
sector that intensely intervened on the sensitivities of modern biotechnology (Damodaran, 2004) 
The concept of ‘agricultural biotechnology’ covers two main categories of activities, one of which 
is characterised by genetic modification using recombinant DNA techniques (GM-technology), 
while the other involves no GM-technology (Ananth, 2015). 
The need to improve the translation of research to product development was stressed by 
Ananth (2005) – in his study on the successes and failures of public R&D efforts in transgenic crop 
development.  The author stated that indigenous transgenes are beginning to become available 
as a result of past decisions of public funded research institutions and funding agencies to invest 
in molecular biology. Additionally, policies to tackle the many complex problems that face product 
development, testing and commercialisation of transgenic crops in India are in the process of 
evolution, presenting an opportunity for improving the policy environment (Ananth, 2005). 
3.3 Health Biotechnology 
India launched the National Biopharma Mission in 2017. It is the first ever Industry-
Academia mission to accelerate biopharmaceutical development in India. In this 
context, the Innovate in India (i3) programme is part of India’s efforts to support an enabling 
ecosystem to promote entrepreneurship and indigenous manufacturing in the 
biopharmaceutical sector. This is a government initiative to focus on consolidated efforts to 
promote product discovery, translational research and early stage manufacturing in the country to 
ensure inclusive innovation. I3 is considered and inclusive innovation programme because it aims 
to fill the gaps in making affordable biopharmaceutical products available (National Biopharma 
Mission, 2019) 
The following is a list of initiatives of the BIRAC - National Biopharma Mission2: 
Part of the National Biopharma Mission is the Vaccine Programme. This has helped to realize 
the lowest cost Rotavirus vaccine which became part of the India’s universal immunization 
programme. Indian medical biotechnology also took major strides towards vaccine for diseases 
like malaria and dengue. One out of every 6 children over the world receive vaccines manufactured 
in India (Department of Biotechnology, 2019).  This first indigenous low cost Rotavirus Vaccine 
                                                   
2 Celebrating Biotechnology: Building India as an Innovation Nation (2019) 
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(which is efficacious in preventing severe rotavirus diarrhoea in low-resource settings) has been 
introduced in 9 Indian states, namely; Odisha, Andhra Pradesh, Haryana, Himachal Pradesh, 
Assam, Tripura, Tamil Nadu, Madhya Pradesh and Rajasthan. The ROTAVAC® has been granted 
WHO prequalification in 2018 (National Biopharma Mission, 2019) 
A technology for rapid diagnosis of celiac disease (CD) in humans was developed in India. 
Celiac Micolisa & Celiac Card kits have been developed through a collaborative, multi-
institutional, inter-disciplinary approach funded by DBT. The kits have been made 
commercially available by a distributor in New Delhi. These indigenous kits are cheaper than 
imported kits (Celebrating Biotechnology: Building India as an Innovation Nation, 2019) 
A programme to address Pre-Term Birth (that is multi-institutional and interdisciplinary in 
scale) was also launched in 2014.  It is a research effort to predict and diagnose pre-term birth 
by enhancing the knowledge of the underlying pathophysiological mechanisms. This programme 
is aimed at addressing a social need as India accounts for 25% of neonatal death globally.  Early 
findings from research done on 1000 mothers indicates indoor pollution is associated with early 
birth (Celebrating Biotechnology: Building India as an Innovation Nation, 2019).   
3.4 Waste to Value 
The Department of Biotechnology is contributing towards new technology development 
through several initiatives under ‘Swachh Bharat’ (also known as the Clean India Mission). 
It is a national campaign to improve the sanitation conditions in India.  Realizing clean energy and 
waste to value are its priority mission areas (Make in India, 2019) 
Innovation has been supported through international collaborations. Such partnerships have 
been leveraged to develop technologies to provide clean water for various end uses like drinking 
and agriculture. DBT has recently achieved significant milestones in bio-energy research and scale 
up from fundamental research to applications to ensure nimbleness and constant access to the 
best technologies. It has developed cost effective and efficient ways to convert waste to energy 
and has set up plants for scaling up the production of energy in different forms (Celebrating 
Biotechnology: Building India as an Innovation Nation Report, 2019).   
Current achievements listed in the report include: 
 First Biomass Ethanol Plant (and Commercialization) which transforms biomass to ethanol 
(along with speed and efficiency) by converting agricultural waste into ethyl alcohol or bio-
ethanol. 
 Five reactors running 24/7 for wastewater treatment and 4 pilots that are operational for 
anaerobic pre-treatment and energy recovery.  
 Novel Bio-Toilet Technologies that provide innovative solutions for less water usage, 
pathogen free and odour free discharge, and bio digestion of the waste.  
 Green Remediation Technology for Wastewater Treatment which is being used in the 
textile industry. 
A complete list of achievements documented by the Department of Biotechnology from the 
Celebrating Biotechnology: Building India as an Innovation Nation Report can be accessed at: 
http://dbtindia.gov.in/sites/default/files/DBT_Report_R2V6_250219%20%281%29.pdf 
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4. Specific Programmes on Biotechnology Innovation 
Some of the key biotechnology innovation programmes in India and their experiences have been 
highlighted to show how innovation was supported. 
4.1 Clean Energy 
Several clean energy initiatives (that incorporate biotechnology into renewable energy 
development) have been started in India. The following is a brief list of developments in this 
area: 
India-Sweden Innovations Accelerator  
The India-Sweden Innovations Accelerator (ISIA) is an initiative with the purpose to bridge 
innovations and entrepreneurship between India and Sweden. ISIA has developed several new 
clean energy technologies, including solar powered water pumps to bring water and 
energy to rural India, and the repurposing of the material used to make airbags to create 
fabric-based biogas reactors (Mission Innovation, 2019 b) 
These developments were supported under ‘Mission Innovation’ (see Section 3.1). The 
support for innovation development was done by (Mission Innovation, 2019 b): 
 Promoting India-centric innovation for clean energy proliferation; 
 National, bilateral, and multilateral joint virtual centres on clean energy themes; 
 Setting up of technology platforms led by industry for clean energy technologies; 
 Scaled-up funding to academic and R&D institutions as well as R&D units in industry for 
research on identified topics relevant to clean energy; 
 National, bilateral, and multilateral capacity building programs in clean energy; 
 Demand-oriented mission programs on clean energy technologies; and 
 Setting up demonstration models/pilot plants for developed technologies.  
String Integrated Methane Platform 
The String Integrated Methane Platform project exploits advances in synthetic biology, 
fermentation technology, chemistry and process engineering to convert methane to 
protein.  The project received support from BIRAC and is also currently being supported under 
Mission Innovation.  The project has been carrying out product development and testing to create 
a protein product for animal feed.  Innovation was supported through research grants both from 
BIRAC (for waste to value funding) and an award from Future Food Asia (as an agri-technology 
product) (Mission Innovation, 2019 c). 
The project is currently being validated at pilot scale and is seeking finance, 
manufacturing capacity and land to scale the technology to commercial production. The 
project scope can be further widened when adapted for other geographies as well as alternate 
sources of methane. Converting methane into protein creates a sustainable protein source that is 
cost effective and can address the growing worldwide protein demand by using a vented or flared 
resource as the input carbon. 
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4.2 Agricultural Technology 
Marker-Assisted Selection of Pearl Millet 
The use of marker-assisted selection (MAS) to improve a locally adapted pearl millet 
variety and the dissemination of a new disease and drought resistant variety is one of 
India’s efforts in agricultural biotechnology. The collaboration of several institutions, 
scientists and funding partners, from tools development to the release of the new variety, 
spanned over twenty years (1989 to 2010).  The objective of the collaboration was to develop 
genetic maps based on molecular markers and use them for better understanding of breeding of 
traits, such as disease resistance and drought tolerance, for the benefit of smallholder pearl 
millet farmers in India (FAO, 2013). 
A key lesson learned from this programme was that the research into improvements in 
breeding and molecular biology are not enough to achieve success in making impact on 
development needs.  Critical to success is the adoption of products of the technology by 
consumers at the farm level.  As such, bridging the research to product gap was a critical 
success factor (FAO, 2013).  
ABF Biotech-KISAN Hub 
ABF Biotech-KISAN Hub is a programme funded by Department of Biotechnology (DBT), 
Government of India (GOI). The programme empowers farmers through science and 
provides solutions to challenges of small and marginal farmers (Celebrating Biotechnology: 
Building India as an Innovation Nation, 2019). 
To support innovation, the programme has done the following: 
 Thematic (Mahila Kisan Biotech) Fellowships have been instituted  
 Strong Scientists-Farmers Interaction Platform created; 
 Demonstrations and scale-up of programmes conducted to address water, soil, seed and 
marketing issues of local farmers with validated technologies;  
 Biotech hubs have been established in 9 Agro-Climatic zones; and 
 An estimated 5300 farmers have benefitted and trained by the programme. 
Further, the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering 
and Physical Sciences Research Council (EPSRC), and Innovate UK, all part of UK Research 
and Innovation (UKRI), and the Department for Biotechnology (DBT) India are co-investing (in 
the Newton-Babha Fund) to support collaborative research projects between UK and 
Indian scientists to increase sustainable production of pulses or oilseeds in India. 
Production of both crops currently falls short of demand in India. However, the outcomes of these 
joint projects will help to enhance food security, reduce the need for imports and meet the 
demands of a growing population in India. The research will improve pulse and oilseed crop 
varieties by understanding and exploiting traits to enhance yield potential, increase tolerance to 
climatic stresses or poor-quality soils, or counter pests or diseases. The programme is supported 
by a joint BBSRC and DBT India investment of £5.3 million (BBSRC, 2019) 
11 
4.3 Health Technology:  
National Biopharma Mission 
The Ministry of Science and Technology launched the National Biopharma Mission (NBM) in 
June 2017 to accelerate biopharmaceutical development (National Biopharma Mission 
Report, 2017). It is an industry- academia collaborative mission of DBT – in collaboration with the 
World Bank for accelerating discovery research to early development of Biopharmaceuticals. The 
programme is being implemented by Biotechnology Industry Research Assistance Council 
(BIRAC, 2019). 
The aim is to enable and nurture an ecosystem for preparing India’s technological and 
product development capabilities in biopharmaceutical to a level that will be globally 
competitive over the next decade. It also aims to transform the health standards of India’s 
population through affordable product development. The Mission is implemented by BIRAC 
(National Biopharma Mission Report, 2017).  
Support for Innovation is done by: 
 Product development: Development of product leads that are at an advanced stages of 
the product development lifecycle and relevant to the public health needs in vaccine, 
biosimilar, medical devices and diagnostics.  
 Infrastructure development: Establishing and strengthening shared infrastructure 
facilities for product development and validation. These would be for all product being 
developed.  
 Accelerating research: Developing human capital by providing specific trainings to 
address the critical skills gap across the product development value chain.  
 Technology transfer: Creating and enhancing technology transfer and intellectual 
property management capacities and capabilities. 
Innovate in India for Inclusiveness Programme (I3)3 
The Innovate in India for Inclusiveness Programme (I3) was launched in 2017 in collaboration 
with the World Bank. The aim of the programme is to boost the growth of domestic 
biopharma industry by accelerating the translation of research concepts into viable 
products and supporting clinical validation (Haththotuwa, 2016).  
It aims to increase indigenous private sector innovation in quality-assured, low-cost 
biopharmaceuticals, medical devices, and diagnostics which address public health 
priorities. Additionally, through BIRAC, it is intended to enable sustainable networks for 
collaboration between industry and academia, and support entrepreneurial ecosystem 
(Haththotuwa, 2016). 
The programme facilitates innovation in biopharmaceutical products and medical devices by: 
                                                   
3 Innovate in India for Inclusiveness is an active programme currently being implemented by the BIRAC in 
association with the World Bank. The mid-term evaluation is due for May 2020 as such immediate outcomes 
were not available. 
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 Expanding the firms’ capabilities to innovate; 
 Upgrading and expanding technology centres in India; 
 Promoting collaboration through Product Development Partnerships (PDPs) targeting 
biopharmaceuticals, diagnostics, and devices addressing public health priorities; 
 Strengthening infrastructure and technology for shared production and validation 
facilities; 
 Developing skills and strengthening training facilities and tools in key areas of need; 
 Developing Technology Transfer Offices (TTOs) in facilities across the country; and 
 Raising awareness within Government of India on global regulatory processes in the 
sector. 
4.4 Waste to Value 
Regarding waste to value, the UK Research and Innovation (UKRI), and the Department for 
Biotechnology (DBT) India, also support multidisciplinary research collaborations between the 
academic and industrial communities based in the UK and India. Research and development 
projects in the area focus on using cutting-edge bioscience, chemistry and engineering 
solutions to reduce industrial waste and pollution in India (BBSRC, 2019). 
The conversion of industrial waste into multiple useful products (a biorefinery approach) 
have been carried out in India to allow for improved value recovery from waste, reducing 
the amounts needing disposal or being released into water courses (BBSRC, 2019). 
Projects funded through this programme provide an opportunity for collaborative learning around 
biorefining technologies. The projects also focus on the reduction and valorisation of Indian 
waste streams – linked to the sugar cane sector, the paper and pulp sectors, and municipal solid 
waste (BBSRC, 2019).  
This programme has supported innovation by enabling academic researchers to work 
with their industrial counterparts – both in India and the UK. This is intended to help 
translate research into waste management solutions for India, with the potential for 
application in other developing countries worldwide (BBSRC, 2019). 
The following projects have been initiated through the UK-India collaboration:  
 Biorefining Value from Industrial Waste;  
 Economic non-food sugar from variable mixed solid waste for high value chemical 
products;  
 Integrated biorefinery for converting paper mill waste into chemical wealth (waste-2-
wealth);  
 Reducing industrial waste from sugarcane processing; and 
 Valorising Waste from Sugar Cane and Associated Industries – via Innovations in Pre-
treatment, Biotransformation and Process Intensification. 
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